_menuCloseDelay=500;
_menuOpenDelay=150;
_subOffsetTop=2;
_subOffsetLeft=-2;
buildafterload="true";


with(menuStyle=new mm_style()){
bordercolor="#ABABAB";
borderwidth="0";
fontfamily="Arial";
fontsize="10pt";
fontstyle="normal";
fontweight="bold";
offcolor="#000000";
oncolor="#0078AE";
outfilter="fade(duration=0.5)";
overfilter="Fade(duration=0.5);Shadow(color=#ADAEAD,Direction=180,Strength=6";
rawcss="padding-left:10px;padding-right:10px";
menubgimage="images/mac_back0.gif";
itemheight="22";
itemwidth="123";
}

with(submenuStyle=new mm_style()){
bordercolor="#838383";
borderwidth="0";
fontfamily="Arial";
fontsize="9pt";
fontstyle="normal";
fontweight="bold";
headercolor="#000000";
image="images/mac_trans.gif";
offcolor="#000000";
oncolor="#0078AE";
onsubimage="images/macarrow_on.gif";
outfilter="fade(duration=0.5)";
overfilter="Fade(duration=0.5);Shadow(color=#ADAEAD,Direction=180,Strength=6";
padding="2";
pagecolor="Black";
separatorcolor="#D2D4D4";
separatorpadding="5";
subimage="images/macarrow_off.gif";
rawcss="padding-left:5px;padding-right:5px";
menubgcolor="#EBF0EC";
menubgimage="images/mac_back0.gif";
}

with(milonic=new menuname("Main Menu")){
position="relative";
menuwidth=738;
style=menuStyle;
alwaysvisible="1";
orientation="horizontal";
aI("text=Home;target=;url=http://www.altheos.com/;align=left;");
aI("showmenu=About Us/OverviewINFO_BAR_MENU;text=About Us;target=;url=About-Us.html;align=left;");
aI("showmenu=Research & Development/PipelineINFO_BAR_MENU;text=Research & Development;target=;url=Research-Development.html;align=left;");
aI("showmenu=ROCK Inhibitors and Glaucoma/ROCK InhibitorsINFO_BAR_MENU;text=ROCK Inhibitors and Glaucoma;target=;url=ROCK-Inhibitors-and-Glaucoma.html;align=left;");
aI("showmenu=Press Releases/9 February 2012 - Phase 2a Clinical TrialINFO_BAR_MENU;text=Press Releases;target=;url=Press-Releases.html;align=left;");
aI("text=Contact Us;target=;url=Contact-Us.html;align=left;");
}

with(milonic=new menuname("About Us/OverviewINFO_BAR_MENU")){
style=submenuStyle;
aI("text=Overview;target=;url=Overview.html;");
aI("text=Management Team;target=;url=Management-Team.html;");
aI("text=Board of Directors;target=;url=Board-of-Directors.html;");
aI("text=Investors;target=;url=Investors.html;");
}

with(milonic=new menuname("Research & Development/PipelineINFO_BAR_MENU")){
style=submenuStyle;
aI("text=Pipeline;target=;url=Pipeline.html;");
aI("text=Clinical Development;target=;url=Clinical-Development.html;");
}

with(milonic=new menuname("ROCK Inhibitors and Glaucoma/ROCK InhibitorsINFO_BAR_MENU")){
style=submenuStyle;
aI("text=ROCK Inhibitors;target=;url=ROCK-Inhibitors.html;");
aI("text=Glaucoma;target=;url=Glaucoma.html;");
aI("text=Glaucoma Therapies;target=;url=Glaucoma-Therapies.html;");
aI("text=Resources;target=;url=Resources.html;");
}

with(milonic=new menuname("Press Releases/9 February 2012 - Phase 2a Clinical TrialINFO_BAR_MENU")){
style=submenuStyle;
aI("text=9 February 2012 - Phase 2a Clinical Trial;target=;url=9-February-2012-Phase-2a-Clinical-Trial.html;");
aI("text=30 September 2010;target=;url=30-September-2010.html;");
aI("text=5 April 2010;target=;url=5-April-2010.html;");
}


 drawMenus();

